Cargando…
Imatinib might constitute a treatment option for lung involvement in COVID-19
Autores principales: | Bernal-Bello, David, Jaenes-Barrios, Beatriz, Morales-Ortega, Alejandro, Ruiz-Giardin, José Manuel, García-Bermúdez, Virginia, Frutos-Pérez, Begoña, Farfán-Sedano, Ana Isabel, de Ancos-Aracil, Cristina, Bermejo, Fernando, García-Gil, Mario, Zapatero-Gaviria, Antonio, San Martín-López, Juan Víctor |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier B.V.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7252139/ https://www.ncbi.nlm.nih.gov/pubmed/32376403 http://dx.doi.org/10.1016/j.autrev.2020.102565 |
Ejemplares similares
-
Early clinical experience with imatinib in COVID-19: Searching for a dual effect
por: Morales-Ortega, Alejandro, et al.
Publicado: (2021) -
Imatinib for COVID-19: A case report
por: Morales-Ortega, Alejandro, et al.
Publicado: (2020) -
Imatinib in COVID-19: hope and caution
por: Bernal-Bello, David, et al.
Publicado: (2021) -
Antibody formation against SARS-CoV-2 in imatinib-treated COVID-19 patients
por: Morales-Ortega, Alejandro, et al.
Publicado: (2022) -
Imatinib: a new chemopreventive option in adenomatous polyposis?
por: Tobon, Angelica, et al.
Publicado: (2020)